Provider profile

ProBioGen.

Biologics CDMOs

ProBioGen documents CHO and HEK293 cell line development, process, analytical and formulation development, and GMP drug substance manufacturing of antibodies and recombinant proteins in single-use bioreactors up to 1000L for preclinical and clinical supply. It also describes process development and GMP manufacturing of viral vectors and vaccines, including in-house vial filling. It is based in Berlin, Germany.

Website: probiogen.de (opens in a new tab)
Sources reviewed: November 4, 2026 · Source pages re-checked within 4 months
First published: November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Analytical development and QC testing3,4
Cell line development7
Formulation development2,4,5
GMP drug product manufacturing1Stated for viral vectors and vaccines (aseptic vial filling); drug product manufacture for proteins and antibodies not established
GMP drug substance manufacturing1,4
Process development1,2Stated for viral vector platforms (LV, AAV, AV, MVA) and customer platforms
Stability studies4
Technology transfer2

Platforms and methods

Mammalian cell culture7
Single-use bioreactors4,9

Drug substance / drug product

Drug product1In-house aseptic vial filling stated for viral vectors and vaccines only, at clinical scale
Drug substance4

Development experience

Development stage

Phase 12,6Stated as first-in-human programs in the CMC Navigator service models
Preclinical1Stated for viral vectors and vaccines; the protein manufacturing page also offers batches for pre-clinical tox studies

Modality

Gene therapies1,8Viral vector producer cell lines (HEK293 for LV, AAV, adenovirus) and GMP manufacturing up to 200L
Monoclonal antibodies4,7
Recombinant proteins2,4
Vaccines6Viral vaccine process development and GMP manufacturing

Locations

Berlin, Germany · Headquarters6
Berlin, Germany · Manufacturing site10Own facilities in Berlin: protein and antibody GMP manufacturing (single-use, up to 1000L, three production lines) and a viral vector GMP suite (up to 200L) with aseptic filling; city of each suite not stated separately

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

GMP / cGMP1,3Stated for viral vector manufacturing; the protein manufacturing page lists a GMP certificate

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

Available capacity, slot timing and scale for your next campaign
Recent experience with your specific modality and expression system or chemistry
Regulatory inspection history of the specific site that would manufacture your product
Technology-transfer approach, timeline and who owns the resulting process knowledge
Analytical and QC release testing done in-house versus subcontracted
Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

1(GMP) Manufacturing for Viral Vectors & Vaccines | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
2Process Development Services for Proteins & Antibodies | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
3Analytics and Quality Control for Viral Vectors & Vaccines | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
4(GMP) Manufacturing Services for Proteins & Antibodies | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
5Formulation Development as a Service |ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
6ProBioGen AG | CDMO Services & Technologies for Biopharmaceuticals (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
7Cell Line Development Services for Proteins & Antibodies | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
8Producer Cell Line Development for Viral Vectors & Vaccines | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
9About Us | ProBioGen AG (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
10ProBioGen to Lead GMP Manufacturing Operations at Berlin Center for Gene and Cell Therapies (BC GCT) (opens in a new tab)ProBioGen · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.